Please find below the overview of all published, ongoing and planned guidelines
Title | Journal | Author | WG/TF/Collaboration |
| Pediatr Nephrol 2020; 35: 1529-1561 | A.Trautmann et al. | Hereditary Glomerulopathies |
European Journal of Human Genetics 2020 | B. Lipska-Zietkiewicz et al. | Hereditary Glomerulopathies | |
| Nature Reviews Nephrology 2021; 17
| O.Boyer et al. | Hereditary Glomerulopathies ESPN |
| Pediatr Transplant . 2021 May;25(3):e13955. | L. Weber et al. | Pediatric Tx CERTAIN |
Distal renal tubular acidosis: ERKNet/ESPN clinical practice points
| Nephrol Dial Transplant 2021; 36: 1585–1596
| F. Trepiccione et al. | Tubulopathy ESPN |
Kidney International 2021; 99: 48–58
| A.Servais et al. | Metabolic and Stone Disorders | |
Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice
| Nephrol Dial Transplant. 2022; | N.Knoers et al. | TF Molecular Diagnostics |
| Nephrol Dial Transplant 2022: 0: 1–12
| S.Kohl et al. | CAKUT and obstructive nephropathies |
Definition, diagnosis and management of fetal lower urinary tract obstruction | Nat Rev Urol. 2022 Feb 8 | V. Capone et al. | CAKUT and obstructive nephropathies |
Nephrol Dial Transplant (2022) 37: 825–839 | R. Müller et al | AD structural kidney disorders ERA | |
| Nature Reviews Nephrology 2023 ;
| J.W.Groothoff et al. | Metabolic and Stone Disorders Oxaleurope |
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolemia: an expert consensus statement from ERKNet and ESPN
| Atherosclerosis, Volume 392, May 2024, 117525 | D. Reijman et al. | Pediatric CKD/Dialysis ESPN |
Nature Reviews Nephrology 2024 | D. Mekahli et al. | AD structural kidney disorders ERA |
Disease | WG/collaboration/lead | Status |
ARPKD | WG CAKUT and Ciliopathies ERKNet/ESPN lead: Max Liebau, Cologne | under development |
Hypomagnesemia | WG tubulopathies lead: T. Nijenhuis, Nijmegen | under development |
Lowe Syndrome | WG Metabolic nephropathies lead: F. Emma, Rome | under development |
Megaureter | WG CAKUT and Ciliopathies eUROGEN/ERKNet lead: Romy Gander(eUROGEN) | under development |
Monoclonal gammopathies of renal significance | WG immune glomerulopathies ERKNet/EuroBloodNet lead: J. Wetzels, Nijmegen | under development |
Alport Syndrome | WG Hereditary glomerulopathies lead: Roser Torra, Barcelona | paper in preparation |
Cardiovascular evaluation and management in ped CKD Guideline | WG PedCKD&Dialysis ERKNet/ESPN lead: Elke Wühl, Heidelberg | paper in preparation |
ACEi/ARB in CKD | WG PedCKD&Dialysis ERKNet/ESPN lead: Rukshana Shroff, London | paper in preparation |
CPG on Spinal Dysraphism | eUROGEN/ERKNet | paper in preparation |
Dent Disease | WG tubulopathies lead: A. Bökenkamp, Amsterdam | paper in preparation |
Bardet Biedl | WG CAKUT ERN-EYE/ERKNEt lead: Hélène Dollfus (ERN-Eye) | final manuscript preparation for submission |
Methylmalonic aciduria | WG Metabolic nephropathies lead: A. Servais, Paris | final manuscript preparation for submission |
Nephrogenic diabetic insipidus | WG Metabolic nephropathies lead: N. Knoers, Groningen/E. Levtchenko, Amsterdam | final manuscript preparation for submission |
Disease | WG collaboration |
IgA nephropathy in children | WG Immune glomerulopathies IPNA |
Consensus paper on genetic testing in adult patients; what are the pros and cons; when and why? | WG Immune glomerulopathies |
Renal amyloidosis | WG Immune glomerulopathies |
Cryoglobulinemic glomerulonephritis | WG Immune glomerulopathies |
Practical guideline on treatment of STEC-HUS | WG Thrombotic Microangiopathies |
Postnatal PUV | WG CAKUT |